X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-22 | EPIX | Parkinson David Ross | CEO | P - Purchase | $2.42 | +24,434 | 56,542 | +76% | +$59,041 | |||||
| M | 2022-12-14 | EPIX | Berger Franklin M | Dir | S - Sale | $2.67 | -272,840 | 684,404 | -29% | -$729,052 | |||||
2022-12-30 | EPIX | Wood David S. | CFO | P - Purchase | $2.60 | +8,302 | 33,343 | +33% | +$21,585 | ||||||
| M | 2022-10-26 | EPIX | Biotech Growth N V | 10% | P - Purchase | $4.11 | +2,000,000 | 7,879,583 | +34% | +$8,219,600 | |||||
2022-07-18 | EPIX | Biotech Growth N V | 10% | P - Purchase | $3.16 | +300,000 | 5,879,583 | +5% | +$946,740 | ||||||
| M | 2022-07-14 | EPIX | Biotech Growth N V | 10% | P - Purchase | $2.93 | +588,869 | 5,579,583 | +12% | +$1,726,226 | |||||
2022-06-30 | EPIX | Parkinson David Ross | CEO | P - Purchase | $2.96 | +4,887 | 32,108 | +18% | +$14,456 | ||||||
2022-04-27 | EPIX | Biotech Growth N V | 10% | S - Sale | $5.85 | -25,100 | 4,990,714 | -1% | -$146,925 | ||||||
2021-08-18 | EPIX | Biotech Growth N V | 10% | P - Purchase | $8.88 | +250,000 | 5,015,814 | +5% | +$2,218,800 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |